Articles From: Foster Wheeler Signs Alliance Agreement with OMV to Foundation Medicine Identifies Novel, Clinically Actionable Gene Fusion NTRK1 in Lung Cancer; Data Published in Nature Medicine


2014/3/25
Foster Wheeler AG (Nasdaq:FWLT) announced today that a subsidiary of its Global Engineering and Construction Group has signed an alliance agreement with OMV to provide integrated project management and engineering, procurement and construction management services.
Sign-up for Foster Wheeler Signs Alliance Agreement with OMV investment picks
2014/2/18
Foster Wheeler AG (Nasdaq:FWLT) announced today that Foster Wheeler USA Corporation, a subsidiary of its Global Engineering and Construction Group, has signed a collaboration agreement with Tecnimont USA Inc., a subsidiary of Maire Tecnimont S.p.A., for front-end engineering (FEED) design, detailed engineering, procurement and construction (EPC) of petrochemicals, chemicals and fertilizer facilities in the United States, Canada, and Mexico.
Sign-up for Foster Wheeler Signs Collaboration Agreement with Tecnimont for North American Chemicals Projects investment picks
Foster Wheeler AG (Nasdaq:FWLT) announced today that a subsidiary of its Global Engineering and Construction Group has signed a technical services agreement with OJSC Khabarovsk Oil Processing Refinery to provide construction management services for the hydroprocessing project at the refinery in Russia’s Far East.
Sign-up for Foster Wheeler Signs Technical Services Agreement with OJSC Khabarovsk Oil Processing Refinery in Russia investment picks
2014/3/13
Foster Wheeler AG (Nasdaq: FWLT) (“Foster Wheeler” or the “Company”) announced today that an indirect wholly owned subsidiary of the Company has entered into a merger implementation agreement (“MIA”) with MDM Engineering Group Limited (AIM:MDM) (“MDM Engineering”) to acquire all of the ordinary shares and options in issue of MDM Engineering in a cash transaction valued at approximately $109 million (the “Transaction”). The Transaction is subject to MDM Engineering shareholder approval and other closing conditions.
Sign-up for Foster Wheeler to Acquire MDM Engineering Group Limited investment picks
2013/10/9
Foster Wheeler AG (Nasdaq:FWLT) plans to hold a conference call on Thursday, November 7, 2013 at 4:00 p.m. Central European Time (10:00 a.m. Eastern Standard Time in the U.S.) to discuss its financial results for the third quarter ended September 30, 2013.
Sign-up for Foster Wheeler to Hold Earnings Conference Call investment picks
2013/11/12
Foster Wheeler AG (Nasdaq:FWLT) announced that Scott Lamb, the company’s Vice President of Investor Relations and Corporate Communications, will represent the company in investor meetings at the Barclays Select Series 2013: Select Growth Conference in New York, New York on November 19, 2013.
Sign-up for Foster Wheeler to Participate in Barclays Select Series 2013: Select Growth Conference investment picks
2013/9/3
Foster Wheeler AG (Nasdaq: FWLT) announced that Franco Baseotto, Executive Vice President, Chief Financial Officer and Treasurer of the company, will make a presentation to investors at the D.A. Davidson 12 th Annual Engineering and Construction Conference in San Francisco on September 10, 2013 at 7:45 a.m. Pacific Time (10:45 a.m. Eastern Time). Foster Wheeler invites investors and those interested to listen to a live audio webcast and view presentation slides via the Investor Relations Presentations/Updates section of its website ( http://www.fwc.com ). A replay of the webcast and presentation slides will also be available on the website for approximately 30 days following the presentation.
Sign-up for Foster Wheeler to Present at D.A. Davidson 12th Annual Engineering and Construction Conference investment picks
Foster Wheeler AG (Nasdaq:FWLT) announced that Scott Lamb, the company’s Vice President of Investor Relations and Corporate Communications, will represent the company in investor meetings at the KeyBanc Capital Markets Engineering, Construction and Utilities Conference in New York, New York, on December 10, 2013.
Sign-up for Foster Wheeler to Present at the KeyBanc Capital Markets 2013 Engineering, Construction and Utilities Conference investment picks
Foster Wheeler AG (Nasdaq: FWLT) announced today that Foster Wheeler Energy Limited (FWEL), the UK subsidiary of its Global Engineering and Construction Group, has won the prestigious Five Star Occupational Health and Safety Management System Audit Award from the British Safety Council.
Sign-up for Foster Wheeler Wins British Safety Council Five Star Occupational Health and Safety Audit Award investment picks
2013/9/25
Foster Wheeler AG (Nasdaq:FWLT) announced today that a subsidiary of its Global Engineering and Construction Group has been awarded a contract by Wood Mackenzie Limited to provide consultancy services for two projects in Peru, namely, the Energy Security and South Pipeline Project and the Energy Node in South Peru Project.
Sign-up for Foster Wheeler Wins Consultancy Services Contract for Pipeline and Power Plant Projects in Peru investment picks
2013/8/5
Foster Wheeler AG (Nasdaq: FWLT) announced today that a subsidiary of its Global Engineering and Construction Group has been awarded an engineering, procurement and construction (EPC) contract by Enterprise Products Operating LLC (“Enterprise”), a subsidiary of Enterprise Products Partners L.P., for a propane dehydrogenation unit (PDH) and associated power, utilities and infrastructure at Mont Belvieu, Texas, U.S. The contract value was not disclosed.
Sign-up for Foster Wheeler Wins Contract for World-Scale Chemicals Facility investment picks
2013/11/18
Foster Wheeler AG (NASDAQ:FWLT) today announced that a subsidiary of its Global Engineering and Construction Group has been awarded a contract by Axion Energy Argentina S.A. (“Axion”), a subsidiary of Bridas Corporation, to provide engineering and procurement services for a new delayed coking unit based on Foster Wheeler’s SYDEC (SM) delayed coking technology, to be installed at the Campana Refinery in Buenos Aires Province, Argentina.
Sign-up for Foster Wheeler Wins Engineering and Procurement Contract for New Coker in Argentina investment picks
2013/10/8
Foster Wheeler AG (Nasdaq:FWLT) announced today that a subsidiary of its Global Engineering and Construction Group has been awarded a contract by Petrochemical Industries Company (K.S.C.) (PIC) for a pre-feasibility study and a market report for a proposed aromatics plant in Kuwait.
Sign-up for Foster Wheeler Wins Pre-Feasibility Study for Aromatics Plant in Kuwait investment picks
2014/1/22
China’s leading investment company Fosun Group (Fosun) and financial services leader Prudential Financial, Inc. (PFI) (NYSE: PRU), which does business as Pramerica in selected countries outside the U.S., announced today an expansion of their strategic relationship, building on their existing joint venture partnerships in life insurance and investment management, and focusing on key areas of growth in China.
Sign-up for Fosun Group and Prudential Financial, Inc. expand strategic partnership in China investment picks
2014/4/10
By Jeffrey Ng HONG KONG--Chinese conglomerate Fosun International Ltd.
Sign-up for Fosun Plans to Raise up to $669 Million From Share Sale investment picks
BELLEVUE, Wash., Nov.
Sign-up for Foundation Bancorp Earns $363,000, or $0.10 Per Diluted Share, in Third Quarter 2013 investment picks
2013/8/5
BELLEVUE, Wash., Aug.
Sign-up for Foundation Bancorp Earns $521,000 in Second Quarter Highlighted by Improved Credit Quality and Operating Efficiencies investment picks
2014/4/3
Foundation Medicine, Inc. (NASDAQ: FMI) and Clovis Oncology, Inc. (NASDAQ: CLVS) today announced the expansion of their ongoing collaboration to incorporate a coordinated regulatory strategy for the development of a novel Premarket Approval (PMA) companion diagnostic test.
Sign-up for Foundation Medicine and Clovis Oncology Expand Collaboration to Develop Novel Companion Diagnostic for Rucaparib in Ovarian Cancer investment picks
2014/2/24
Foundation Medicine, Inc. (NASDAQ: FMI) today announced the results of a new study demonstrating that FoundationOne™ identified genomic alterations linked to targeted therapies or clinical trials in 71% (20/28) of patients with intrahepatic cholangiocarcinoma (ICC). ICC is a form of primary liver cancer that is rapidly increasing in incidence, typically associated with poor prognosis and often treated with systemic, non-targeted therapies extrapolated from treatments used in other gastrointestinal cancers.
Sign-up for Foundation Medicine and Collaborators Identify High Incidence of Genomic Alterations Linked to Targeted Therapies in Liver Cancer; Data Published in The Oncologist investment picks
2014/2/25
Foundation Medicine, Inc. (NASDAQ:FMI) today announced total revenue of $9.7 million in the 2013 fourth quarter, compared to $8.2 million in the 2013 third quarter.
Sign-up for Foundation Medicine Announces 2013 Fourth Quarter and Year-End Results and Recent Highlights investment picks
Foundation Medicine, Inc. (NASDAQ:FMI) today announced that 2,577 FoundationOne™ tests were reported to ordering oncologists in the quarter ended September 30, 2013, an increase from the 1,626 reported in the second quarter of 2013.
Sign-up for Foundation Medicine Announces 2013 Third Quarter Results investment picks
2013/9/30
Foundation Medicine, Inc. today announced the closing of its initial public offering of 6,772,221 shares of common stock at a public offering price of $18.00 per share, before underwriting discounts, which includes the exercise in full by the underwriters of their option to purchase up to 883,333 additional shares of common stock.
Sign-up for Foundation Medicine Announces Closing of Initial Public Offering and Exercise of Over-Allotment Option investment picks
2014/4/2
Foundation Medicine, Inc. (NASDAQ:FMI) today announced that new clinical data including additional validation for FoundationOne™ and FoundationOne™ Heme will be presented at the American Association of Cancer Research (AACR) Annual Meeting 2014 taking place April 5-9, 2014 at the San Diego Convention Center.
Sign-up for Foundation Medicine Announces New Data Highlighting FoundationOne™ and FoundationOne™ Heme to be Presented at the AACR Annual Meeting 2014 investment picks
2013/10/20
Foundation Medicine, Inc. (NASDAQ: FMI) today announced that results from a 24-month, multi-institution collaboration demonstrating the analytic validation of its cancer genomic profiling assay, FoundationOne™, were published in the current online edition of Nature Biotechnology.
Sign-up for Foundation Medicine Announces Publication of Analytic Validation Study of FoundationOne™ in Nature Biotechnology investment picks
2014/2/11
Foundation Medicine, Inc. (NASDAQ:FMI) today announced that financial results for the company’s fourth quarter and year ended December 31, 2013 will be released on Tuesday, February 25, 2014.
Sign-up for Foundation Medicine Announces Timing for Fourth Quarter and Year-End 2013 Financial Results and Conference Call investment picks
Foundation Medicine, Inc. (NASDAQ: FMI) today announced that financial results for the company’s third quarter ended September 30, 2013 will be released on Wednesday, November 6, 2013.
Sign-up for Foundation Medicine Announces Timing for Third Quarter 2013 Financial Results and Conference Call investment picks
2014/1/9
Foundation Medicine, Inc. (NASDAQ:FMI) today announced the discovery of a high incidence of ERBB2 ( HER2 ) extracellular domain alterations in patients with micropapillary urothelial carcinoma (MPUC), a particularly aggressive form of urinary bladder cancer, using FoundationOne™. The research was published in the current edition of Clinical Cancer Research 1 .
Sign-up for Foundation Medicine Discovers High Incidence of Clinically Actionable ERBB2 (HER2) Alterations in Aggressive Form of Bladder Cancer; Data Published in Clinical Cancer Research investment picks
Foundation Medicine today announced it has extended and expanded its ongoing collaboration with Novartis to provide molecular information and comprehensive genomic profiling analysis in support of many of Novartis’ clinical oncology programs.
Sign-up for Foundation Medicine Extends and Expands Collaboration to Provide Molecular Information and Genomic Profiling for Clinical Oncology Programs investment picks
2013/10/27
Foundation Medicine, Inc. (NASDAQ:FMI) today announced that the discovery of a novel and potentially clinically actionable oncogenic gene fusion in lung cancer, NTRK1 , using FoundationOne™, was published in the current online edition of Nature Medicine 1 .
Sign-up for Foundation Medicine Identifies Novel, Clinically Actionable Gene Fusion NTRK1 in Lung Cancer; Data Published in Nature Medicine investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Foster Wheeler Signs Alliance Agreement with OMV to Foundation Medicine Identifies Novel, Clinically Actionable Gene Fusion NTRK1 in Lung Cancer; Data Published in Nature Medicine
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity